Bonapace CR - Search Results

1

Assessment of differences in antimicrobial effect determined with two in vitro pharmacodynamic models: impact of surface area to volume ratio.

White RL, Bonapace CR, Friedrich LV, Rybak MJ, Cappelletty DM, Mercier RC, Houlihan HH, Aeschlimann JR, Bosso JA. White RL, et al. Among authors: bonapace cr. Pharmacotherapy. 2003 May;23(5):603-8. doi: 10.1592/phco.23.5.603.32193. Pharmacotherapy. 2003. PMID: 12741434

2

Differences in antimicrobial drug exposure in patients with various degrees of renal function based on recommendations from dosing references.

Bonapace CR, White RL, Frich LV, Bosso JA. Bonapace CR, et al. Pharmacotherapy. 2002 Sep;22(9):1097-104. doi: 10.1592/phco.22.13.1097.33520. Pharmacotherapy. 2002. PMID: 12222544 Clinical Trial.

3

Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection.

Bonapace CR, Friedrich LV, Bosso JA, White RL. Bonapace CR, et al. Antimicrob Agents Chemother. 2002 Nov;46(11):3574-9. doi: 10.1128/AAC.46.11.3574-3579.2002. Antimicrob Agents Chemother. 2002. PMID: 12384367 Free PMC article.

4

A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis.

Bosso JA, Bonapace CR, Flume PA, White RL. Bosso JA, et al. Among authors: bonapace cr. Pharmacotherapy. 1999 May;19(5):620-6. doi: 10.1592/phco.19.8.620.31525. Pharmacotherapy. 1999. PMID: 10331825 Clinical Trial.

5

Comparison of methods of interpretation of checkerboard synergy testing.

Bonapace CR, Bosso JA, Friedrich LV, White RL. Bonapace CR, et al. Diagn Microbiol Infect Dis. 2002 Dec;44(4):363-6. doi: 10.1016/s0732-8893(02)00473-x. Diagn Microbiol Infect Dis. 2002. PMID: 12543542

6

Pharmacokinetics of cefepime in patients with thermal burn injury.

Bonapace CR, White RL, Friedrich LV, Norcross ED, Bosso JA. Bonapace CR, et al. Antimicrob Agents Chemother. 1999 Dec;43(12):2848-54. doi: 10.1128/AAC.43.12.2848. Antimicrob Agents Chemother. 1999. PMID: 10582870 Free PMC article. Clinical Trial.

7

Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods.

Bonapace CR, White RL, Friedrich LV, Bosso JA. Bonapace CR, et al. Diagn Microbiol Infect Dis. 2000 Sep;38(1):43-50. doi: 10.1016/s0732-8893(00)00163-2. Diagn Microbiol Infect Dis. 2000. PMID: 11025183

8

The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.

Bonapace CR, Mays DA. Bonapace CR, et al. Ann Pharmacother. 1997 Jul-Aug;31(7-8):907-13. doi: 10.1177/106002809703100719. Ann Pharmacother. 1997. PMID: 9220055 Review.

9

Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.

Bhattaram VA, Bonapace C, Chilukuri DM, Duan JZ, Garnett C, Gobburu JV, Jang SH, Kenna L, Lesko LJ, Madabushi R, Men Y, Powell JR, Qiu W, Ramchandani RP, Tornoe CW, Wang Y, Zheng JJ. Bhattaram VA, et al. Clin Pharmacol Ther. 2007 Feb;81(2):213-21. doi: 10.1038/sj.clpt.6100051. Clin Pharmacol Ther. 2007. PMID: 17259946

10

Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop.

Khin NA, Francis G, Mulinde J, Grandinetti C, Skeete R, Yu B, Ayalew K, Cho SJ, Fisher A, Kleppinger C, Ayala R, Bonapace C, Dasgupta A, Kronstein PD, Vinter S. Khin NA, et al. Clin Pharmacol Ther. 2020 Nov;108(5):949-963. doi: 10.1002/cpt.1794. Epub 2020 Mar 28. Clin Pharmacol Ther. 2020. PMID: 31958142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters